Business Description
Sinsin Pharmaceutical Co Ltd
ISIN : KR7002800001
Compare
Compare
Traded in other countries / regions
002800.Korea IPO Date
2017-02-28Description
Sinsin Pharmaceutical Co Ltd is a pharmaceutical company, which manufactures and sells pharmaceutical products in South Korea. It offers pain relief and treatment products, including pain relief patches, creams, and sprays; insects care products, such as mosquito repellents and anti-perspirants; foot care products; head lice and dandruff care products; protection bands; and other products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.66 | |||||
| Debt-to-EBITDA | 4.19 | |||||
| Interest Coverage | 3.08 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.18 | |||||
| Beneish M-Score | -2.59 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 15 | |||||
| 3-Year EBITDA Growth Rate | 45.2 | |||||
| 3-Year FCF Growth Rate | 52.7 | |||||
| 3-Year Book Growth Rate | 3.5 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.36 | |||||
| 9-Day RSI | 47.17 | |||||
| 14-Day RSI | 43.34 | |||||
| 6-1 Month Momentum % | 4.6 | |||||
| 12-1 Month Momentum % | -6.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.94 | |||||
| Quick Ratio | 0.67 | |||||
| Cash Ratio | 0.05 | |||||
| Days Inventory | 81.99 | |||||
| Days Sales Outstanding | 104.34 | |||||
| Days Payable | 38.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.11 | |||||
| Dividend Payout Ratio | 0.21 | |||||
| Forward Dividend Yield % | 1.11 | |||||
| 5-Year Yield-on-Cost % | 1.11 | |||||
| Shareholder Yield % | -0.38 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.47 | |||||
| Operating Margin % | 5.9 | |||||
| Net Margin % | 3.77 | |||||
| FCF Margin % | 3.25 | |||||
| ROE % | 6.27 | |||||
| ROA % | 3.13 | |||||
| ROIC % | 5.02 | |||||
| ROC (Joel Greenblatt) % | 6.46 | |||||
| ROCE % | 8.41 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.79 | |||||
| PE Ratio without NRI | 19.34 | |||||
| Shiller PE Ratio | 24.71 | |||||
| Price-to-Owner-Earnings | 493.29 | |||||
| PEG Ratio | 0.95 | |||||
| PS Ratio | 0.79 | |||||
| PB Ratio | 1.25 | |||||
| Price-to-Tangible-Book | 1.27 | |||||
| Price-to-Free-Cash-Flow | 24.07 | |||||
| Price-to-Operating-Cash-Flow | 12.03 | |||||
| EV-to-EBIT | 19.98 | |||||
| EV-to-EBITDA | 11.85 | |||||
| EV-to-Revenue | 1.16 | |||||
| EV-to-FCF | 35.47 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.77 | |||||
| Price-to-Graham-Number | 1.04 | |||||
| Earnings Yield (Greenblatt) % | 5.01 | |||||
| FCF Yield % | 4.16 | |||||
| Forward Rate of Return (Yacktman) % | 17.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinsin Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 105,729.887 | ||
| EPS (TTM) (â‚©) | 261 | ||
| Beta | 0.54 | ||
| Volatility % | 40.57 | ||
| 14-Day RSI | 43.34 | ||
| 14-Day ATR (â‚©) | 183.301962 | ||
| 20-Day SMA (â‚©) | 5423.5 | ||
| 12-1 Month Momentum % | -6.72 | ||
| 52-Week Range (â‚©) | 5040 - 8100 | ||
| Shares Outstanding (Mil) | 15.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sinsin Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sinsin Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sinsin Pharmaceutical Co Ltd Frequently Asked Questions
What is Sinsin Pharmaceutical Co Ltd(XKRX:002800)'s stock price today?
The current price of XKRX:002800 is â‚©5420.00. The 52 week high of XKRX:002800 is â‚©8100.00 and 52 week low is â‚©5040.00.
When is next earnings date of Sinsin Pharmaceutical Co Ltd(XKRX:002800)?
The next earnings date of Sinsin Pharmaceutical Co Ltd(XKRX:002800) is .
Does Sinsin Pharmaceutical Co Ltd(XKRX:002800) pay dividends? If so, how much?
The Dividend Yield %  of Sinsin Pharmaceutical Co Ltd(XKRX:002800) is 1.11% (As of Today), Highest Dividend Payout Ratio of Sinsin Pharmaceutical Co Ltd(XKRX:002800) was 0.21. The lowest was 0.09. And the median was 0.17. The  Forward Dividend Yield % of Sinsin Pharmaceutical Co Ltd(XKRX:002800) is 1.11%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers